Aastrom Biosciences (ASTM)

Aastrom Biosciences' (ASTM) CEO Nick Colangelo on Q3 2014 Results - Earnings Call Transcript
Nov. 13, 2014 | Price: Free! | Source: Seeking Alpha

Aastrom Biosciences (ASTM) Q2 2014 Results - Earnings Call Webcast
Aug. 14, 2014 | Price: Free! | Source: Seeking Alpha

Aastrom Biosciences' (ASTM) CEO Dominick Colangelo on Q2 2014 Results - Earnings Call Transcript
Aug. 14, 2014 | Price: Free! | Source: Seeking Alpha

Aastrom Biosciences' (ASTM) CEO Dominick Colangelo on Q1 2014 Results - Earnings Call Transcript
May 15, 2014 | Price: Free! | Source: Seeking Alpha

Aastrom Biosciences' CEO Discusses Q4 2013 Results - Earnings Call Transcript
March 13, 2014 | Price: Free! | Source: Seeking Alpha

Aastrom Biosciences Q3 2013 Earnings Conference Call Transcript
Nov. 12, 2013 | Price: $106.00 | Source: Thomson

Aastrom Biosciences' CEO Discusses Q3 2013 Results - Earnings Call Transcript
Nov. 12, 2013 | Price: Free! | Source: Seeking Alpha

Aastrom Biosciences Q2 2013 Earnings Conference Call Transcript
Aug. 15, 2013 | Price: $106.00 | Source: Thomson

Aastrom Biosciences Management Discusses Q2 2013 Results - Earnings Call Transcript
Aug. 15, 2013 | Price: Free! | Source: Seeking Alpha

Aastrom Biosciences Management Discusses Q1 2013 Results - Earnings Call Transcript
May 9, 2013 | Price: Free! | Source: Seeking Alpha

Aastrom Biosciences Q1 2013 Earnings Conference Call Transcript
May 8, 2013 | Price: $106.00 | Source: Thomson

Aastrom Biosciences Management Discusses Q4 2012 Results - Earnings Call Transcript
March 18, 2013 | Price: Free! | Source: Seeking Alpha

Aastrom Biosciences Q4 2012 Earnings Conference Call Transcript
March 18, 2013 | Price: $106.00 | Source: Thomson

Aastrom Biosciences' CEO Discusses Q3 2012 Results - Earnings Call Transcript
Nov. 9, 2012 | Price: Free! | Source: Seeking Alpha

Aastrom Biosciences Q3 2012 Earnings Conference Call Transcript
Nov. 8, 2012 | Price: $54.00 | Source: Thomson

Aastrom Biosciences' CEO Discusses Q2 2012 Results - Earnings Call Transcript
Aug. 8, 2012 | Price: Free! | Source: Seeking Alpha

Aastrom Biosciences Q2 2012 Earnings Conference Call Transcript
Aug. 7, 2012 | Price: $54.00 | Source: Thomson

Aastrom Biosciences, Inc. Q2 2008 Earnings Call Transcript
Feb. 8, 2008 | Price: Free! | Source: Seeking Alpha

Recent filings

Aastrom: Vericel Announces Fda Acceptance Of Biologics License Application For Nexobrid For The Treatment Of Severe Thermal Burns - Sept. 16, 2020

Departure of Directors or Certain - Sept. 8, 2020

Securities to be offered to employees in employee benefit plans - Aug. 6, 2020

Aastrom Biosciences Just Filed Its Quarterly Report: Net Loss Per Common ... - Aug. 5, 2020

Aastrom: Vericel Reports Second Quarter 2020 Financial Results - Aug. 5, 2020

Aastrom: Vericel Announces Preliminary Second Quarter 2020 Financial Results And Provides Business Updates - July 9, 2020

Aastrom: Vericel Announces Submission Of Biologics License Application To The Fda For Nexobrid For The Treatment Of Severe Thermal Burns - June 30, 2020

Aastrom Biosciences insider just cashed-in 14,751 options - June 24, 2020

Aastrom Biosciences insider just disposed of 1,112 shares - June 18, 2020

Brown Capital Management, LLC just provided an update on share ownership of Aastrom Biosciences - June 10, 2020

Aastrom Biosciences Just Filed Its Quarterly Report: Net Loss Per Common ... - May 11, 2020

Aastrom Biosciences insider just picked up 13,125 shares - May 8, 2020

Aastrom: Vericel Reports First Quarter 2020 Financial Results - May 5, 2020

Aastrom Biosciences insider just picked up 1,750 shares - May 1, 2020

Aastrom Biosciences insider just picked up 1,750 shares - May 1, 2020

Departure of Directors or Certain - May 1, 2020

Aastrom Biosciences insider just picked up 1,750 shares - May 1, 2020

Aastrom Biosciences insider just picked up 1,750 shares - May 1, 2020

Aastrom Biosciences insider just picked up 1,750 shares - May 1, 2020

Aastrom Biosciences insider just picked up 1,750 shares - May 1, 2020

Aastrom: Form, Schedule Or Registration Statement No Filing Party: Date Filed: VERICEL CORPORATION SUPPLEMENT TO PROXY STATEMENT DATED MARCH 20, 2020 - April 10, 2020

Aastrom Biosciences insider just picked up 91,157 shares - April 3, 2020

Current report, items 2.02, 7.01, 8.01, and 9.01 - April 2, 2020

Aastrom Biosciences releases salary data. CEO sees compensation rise 106% - March 20, 2020

Aastrom Biosciences Just Filed Its Annual Report: Net Earnings (Loss) ... - Feb. 25, 2020

Aastrom: Vericel Reports Fourth Quarter And Full-Year 2019 Financial Results And Provides Full-Year 2020 Financial Guidance - Feb. 25, 2020

Aastrom Biosciences insider just picked up 23,438 shares - Feb. 18, 2020

Statement of acquisition of beneficial ownership by individuals - Feb. 14, 2020

Mitchell Blutt just provided an update on share ownership of Aastrom Biosciences - Feb. 14, 2020

just provided an update on share ownership of Aastrom Biosciences - Feb. 14, 2020

Aastrom Biosciences insider was just granted 255,000 options and restricted shares - Feb. 13, 2020

James E. Flynn just provided an update on share ownership of Aastrom Biosciences - Feb. 13, 2020

Aastrom Biosciences insider was just granted 102,000 options and restricted shares - Feb. 13, 2020

Aastrom Biosciences insider was just granted 55,250 options and restricted shares - Feb. 13, 2020

Aastrom Biosciences insider was just granted 119,000 options and restricted shares - Feb. 13, 2020

The Vanguard Group just provided an update on share ownership of Aastrom Biosciences - Feb. 12, 2020

Aastrom Biosciences insider just picked up 282 shares - Feb. 11, 2020

Aastrom Biosciences insider just picked up 3,758 shares - Feb. 10, 2020

Aastrom Biosciences insider just picked up 1,112 shares - Feb. 10, 2020

Aastrom Biosciences insider just picked up 1,540 shares - Feb. 10, 2020

Aastrom Biosciences insider just cashed-in 15,047 options - Nov. 12, 2019

Aastrom: 02. Results Of Operations And Financial Condition - Nov. 5, 2019

Aastrom Biosciences Just Filed Its Quarterly Report: Net Earnings (Loss) ... - Nov. 5, 2019

Aastrom Biosciences insider just picked up 36,077 shares - Oct. 3, 2019

Aastrom Biosciences insider just cashed-in 58,125 options - Oct. 3, 2019

Aastrom Biosciences insider just picked up 56,250 shares - Oct. 3, 2019

Aastrom Biosciences insider just cashed-in 17,000 options - Aug. 16, 2019

Aastrom Biosciences Just Filed Its Quarterly Report: Net Loss Per Common ... - Aug. 6, 2019

Aastrom: 02. Results Of Operations And Financial Condition - Aug. 6, 2019

Aastrom Biosciences insider just cashed-in 17,000 options - July 17, 2019

Aastrom Biosciences insider just declared owning 644 shares of Aastrom Biosciences - June 18, 2019

Aastrom Biosciences insider just cashed-in 17,500 options - June 12, 2019

Departure of Directors or Certain - June 3, 2019

Aastrom Biosciences insider just cashed-in 17,500 options - May 14, 2019

Aastrom Biosciences Just Filed Its Quarterly Report: Net Loss Per Common ... - May 7, 2019

Aastrom: 02. Results Of Operations And Financial Condition - May 7, 2019

Entry into a Material Definitive - May 7, 2019

Aastrom: Vericel Enters Into Exclusive License Agreement With Mediwound For North American Rights To Nexobrid, A Biological Orphan Product For Debridement Of Severe Thermal Burns - May 7, 2019

Aastrom Biosciences insider was just granted 14,875 options and restricted shares - May 3, 2019

Aastrom Biosciences insider was just granted 14,875 options and restricted shares - May 3, 2019

Aastrom Biosciences insider just cashed-in 7,500 options - May 3, 2019

Aastrom Biosciences insider was just granted 14,875 options and restricted shares - May 3, 2019

Aastrom Biosciences insider was just granted 14,875 options and restricted shares - May 3, 2019

Aastrom Biosciences insider was just granted 14,875 options and restricted shares - May 3, 2019

Securities to be offered to employees in employee benefit plans, post-effective amendments - May 1, 2019

Securities to be offered to employees in employee benefit plans, post-effective amendments - May 1, 2019

Departure of Directors or Certain - May 1, 2019

Securities to be offered to employees in employee benefit plans - May 1, 2019

Securities to be offered to employees in employee benefit plans, post-effective amendments - May 1, 2019

Securities to be offered to employees in employee benefit plans, post-effective amendments - May 1, 2019

Securities to be offered to employees in employee benefit plans, post-effective amendments - May 1, 2019

Securities to be offered to employees in employee benefit plans, post-effective amendments - May 1, 2019

Securities to be offered to employees in employee benefit plans, post-effective amendments - May 1, 2019

Aastrom Biosciences insider just cashed-in 15,625 options - April 10, 2019

Aastrom Biosciences releases salary data. CEO sees compensation rise 77% - March 20, 2019

Aastrom Biosciences insider just disposed of 10,000 shares - March 12, 2019

Aastrom Biosciences insider just cashed-in 7,500 options - March 4, 2019

Aastrom: 02. Results Of Operations And Financial Condition - Feb. 26, 2019

Aastrom Biosciences Just Filed Its Annual Report: Net Loss Per Share A... - Feb. 26, 2019

Aastrom Biosciences insider just picked up 36,192 shares - Feb. 19, 2019

Strategos Fund, L.P. just provided an update on share ownership of Aastrom Biosciences - Feb. 14, 2019

Mitchell Blutt just provided an update on share ownership of Aastrom Biosciences - Feb. 14, 2019

Statement of acquisition of beneficial ownership by individuals - Feb. 14, 2019

James E. Flynn just provided an update on share ownership of Aastrom Biosciences - Feb. 12, 2019

The Vanguard Group just provided an update on share ownership of Aastrom Biosciences - Feb. 12, 2019

Aastrom Biosciences insider was just granted 134,500 options and restricted shares - Feb. 8, 2019

Aastrom Biosciences insider was just granted 337,750 options and restricted shares - Feb. 8, 2019

Aastrom Biosciences's Chief Operating Officer just picked up 1,487 shares - Feb. 8, 2019

Aastrom Biosciences insider was just granted 154,000 options and restricted shares - Feb. 8, 2019

Aastrom Biosciences insider just picked up 17,500 shares - Jan. 24, 2019

Aastrom Biosciences insider just disposed of 8,711 shares - Jan. 16, 2019

Termination of a Material Definitive - Dec. 20, 2018

Aastrom Biosciences insider just cashed-in 15,625 options - Dec. 12, 2018

Aastrom Biosciences insider just cashed-in 8,500 options - Dec. 4, 2018

Aastrom: 02. Results Of Operations And Financial Condition - Nov. 6, 2018

James E. Flynn just provided an update on share ownership of Aastrom Biosciences - Oct. 22, 2018

Aastrom Biosciences insider just cashed-in 15,000 options - Oct. 17, 2018

Aastrom Biosciences insider just cashed-in 15,000 options - Sept. 12, 2018

Aastrom Biosciences insider just cashed-in 9,000 options - Sept. 6, 2018

Aastrom Biosciences Just Received a Notice of Effectiveness - Aug. 28, 2018

Sorry, no schedule available for this company

Owner Shares% of PortfolioAs Of
1. Consonance Capman GP LLC 2,086,028 N/A Dec. 31, 2015
2. UBS AG 1,373 N/A Sept. 30, 2014
 


Feedback